BDBM72380 MLS000666591::N-[4-[(2-bromanyl-5-nitro-phenyl)carbonylamino]-2-methoxy-phenyl]furan-2-carboxamide::N-[4-[(2-bromo-5-nitro-benzoyl)amino]-2-methoxy-phenyl]-2-furamide::N-[4-[(2-bromo-5-nitrobenzoyl)amino]-2-methoxyphenyl]furan-2-carboxamide::N-[4-[[(2-bromo-5-nitrophenyl)-oxomethyl]amino]-2-methoxyphenyl]-2-furancarboxamide::N-{4-[(2-bromo-5-nitrobenzoyl)amino]-2-methoxyphenyl}-2-furamide::SMR000268249::cid_3816795

SMILES O=C1c2cc(F)c(Cl)cc2N2CN1c1ccc(=O)[nH]c1NCCCc1cc(F)ccc12

InChI Key InChIKey=KUXDRMBOFDCYMQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72380   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72380BDBM72380(3-Chloro-2,8-difluoro-10,11,12,13-tetrahydro-19H-5...)
Affinity DataIC50: 7.94nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent